| Question |
Answer |
| What is Q-banding? |
Stain with quinacrine mustard (fluorescent). Bright Q bands correspond to dark G bands. Detects heteromorphisms of satellite repeats. |
| What is G-banding? |
Giemsa black stain most commonly used in karyotyping |
| What is R-banding? |
Heat the DNA before staining to improve resolution of bands. Reversed banding patterns. |
| Metacentric Chromosome |
arms are approximately equal length |
| Submetacentric Chromosome |
Centromere is off-center |
| Acrocentric chromosome |
Centromere near one end (13, 14, 15, 21, 22) |
| Telocentric chromosome |
only one arm (occurs sometimes w/chromosome rearrangements) |
| What is C banding? |
Stains centromere and constitutive heterochromatin only |
| What is SKY? |
Spectral karyotyping (uses 24 different colored fluorescent probes simultaneously) |
| Heteroploid |
any chromosome number other than 46 |
| Euploid |
Exact multiple of 23 chromosomes |
| Aneuploid |
Any chromosome number that is not a multiple of 23. Usually caused by nondisjunction. |
| Triploidy & Tetraploidy |
Embryonic Lethal, results from failure of complete cleavage of the zygote at an early stage |
| Isochromosome |
one arm is missing & the other is duplicated (haploinsufficiency of one arm and partial trisomy of the other). e.g. i(Xq) |
| Paracentric Inversion vs. Pericentric Inversion |
Para = 2 breaks occur in one arm to one side of the centromere, usually no change in phenotype. Peri = 2 breaks occur in one arm around the centromere, can lead to duplication and deficiency during meiosis. |
| Balanced Reciprocal Translocation |
Reciprocal exchange of broken-off segments between 2 different chromosomes. Very common, risk of abnormal progeny. Forms quadrivalent during meiosis. |
| Robertsonian Translocation |
2 acrocentric chromosomes fuse near the centromere and lose short arms. (all acrocentric short arms contain repeats of ribosomal genes, so usually not deleterious). Risk of unbalanced progeny. |
| Isodisomy vs. Heterodisomy |
(= uniparental disomy), Isodisomy = 2 identical chromosomes from same parent, Heterodisomy = 2 nonidentical chromosomes from same parent |
| Mole |
When sperm fertilizes egg w/out nucleus. Develops into disorganized mass, can cause choriocarcinoma. |
| Ovarian Teratoma |
46, XX containing only maternal chromosomes. Paternal --> extraembryonic devel. and maternal --> fetal devel. |
| Supernumerary chromosome derived from a paracentromeric region |
Typically has clinical repercussions |
| Name the potential causes of Down Syndrome: |
1. Trisomy 21, 2. Robertsonian Translocation (46 chromosomes), 3. 21q21q Translocation (isochromosome origin), 4. Mosaic Down Syndrome, 5. Partial Trisomy 21 |
| Marker Chromosome |
Supernumerary chromosome, very small, risk of clinical disorder depend on genes in marker |
| What are the 3 genetic disorders showing complete trisomy of an autonomic chromosome? |
21 (Down Syndrome), 18, and 13 |
| 47 XXY |
Klinefelter syndrome (male). More X's = still Klinefelter, but more severe phenotype. paternal nondisjunction of meiosis 1. |
| 45 X |
Turner syndrome (female), very uncommon (1/4000) short, webbed neck, cardiovascular abnormalities, normal intelligence
|
| What is the region of the sex chromosomes that undergoes recombination? |
Pseudoautosomal. When recombination extends beyond this region, XX males and XY females can occur. |
| X inactivation |
X inactivation center at proximal Xq and XIST gene (only expressed from inactive X). X inactivation is usually random, but a damaged X is always inactivated. |
| 47 XYY |
normal male phenotype (paternal nondisjunction at meiosis). slightly lower IQ, greater risk of ADHD & hyperactivity. paternal nondisjunction of meiosis 2. |
| 47 XXX |
Trisomy X. Lower IQ, learning disabilities. 48XXXX & 49 XXXXX are more severe. |
| Segmental Aneusomy |
microdeletions producing haploinsufficiency for key genes |
| What is the cell cycle in which most chromosome analysis is conducted? |
Metaphase |
| Name the 6 common indications for chromosome evaluation: |
1. Problems with early growth and development, 2. stillbirth and neonatal death, 3. fertility problems, 4. family history, 5. Neoplasia, 6. Pregnancy in woman of advanced age |
| Which cell types are used in cell culture for FISH analysis? |
Leukocytes & Lymphoblastoids (peripheral blood), fibroblasts (skin biopsy), bone marrow, fetal amniocytes or chorionic villus biopsy |
| What are 3 identifying features of each chromosome? |
1. position of the centromere, 2. banding pattern, 3. size |
| What are the chromosomal features & types of genetic testing available for fragile X? |
1. expose cells to chemicals that inhibit DNA synthesis, or 2. detect expansion of the CGG repeat in the FMR1 gene |
| What are the 3 types of FISH probes? |
1. Locus-specific probes (look for presence/absence of particular genes), 2. repetitive DNA probes (detect satellite DNA/centromeres/telomeres), 3. whole chromosome probes (bind segmentally along length of chromosome: painting) |
| What are the limitations of microarray CGH? |
Measures relative copy number of DNA sequences, but not whether they have been translocated/rearranged |
| What is the incidence of...(1) sex chromosome aneuploidy, (2) autosomal aneuploidy, (3) structural abnormalities ? |
(1) sex chromosome aneuploidy 1/350 male -- 1/550 female, (2) autosomal aneuploidy 1/700, (3) structural abnormalities 1/375. TOTAL = 1/150 |
| What are the chromosomal abnormalities leading to spontaneous abortion? |
1. Autosomal trisoym (0.52), 2. Autosomal monosomy (<0.01), 3. Triploidy (0.16), 4. Tetraploidy (0.06) |
| Describe the difference between Prader Willi & Angelman Syndrome: |
Prader Willi = lacking chromosome 15 from FATHER, Angelman = lacking lacking chromosome 15 from MOTHER |
| What are the clinical features of Trisomy 18, 13, and 21 (besides mental retardation)? |
Down Syndrome = loose neck skin, protruding tongue, heart disease. Patau Syndrome (Trisomy 13) = cleft palate, microcephaly, clenched hands, rocker-bottom feet, polydactyly. Trisomy 18 = cleft palate, clenched hands, receding jaw. |
| Name two cytogenetic mechanisms for mosaicism: |
mitotic event:
1. nondisjunction in an early postzygotic mitotic division, 2. trisomy of zygote that is lost in an early postzygotic division |
| What is the mechanism of XX males and XY females? |
SRY gene in sex determining region of Y chromosome (P11.3) is located right next to pseudoautosomal region |
| What is the difference between recombination and sister chromatid exchange? |
Meiosis recombination = exchange of different codes, Mitosis sister chromatid exchange = exchange of identical genetic code |
| How can autosomal dominant be distinguished from X-linked dominant and pseudoautosomal dominant mutations? |
X-linked dominant cannot be passed from father to son (son have an autosomal dominant-like pattern if recombination transfers X-linked genes to the Y chromosome (mostly female transmission with a few male) |
| What is anticipation? |
When a disease phenotype is expressed at earlier and earlier ages as it is passed from generation to generation. Common in unstable repeat expansion diseases. |
| Fragile X Syndrome |
fragile site on the q arm fails to condense during mitosis. 50% penetrance in females. Caused by an unstable repeat expansion. |
| Mitochondrial genetic bottleneck |
# mitochondria in the oocyte is severely reduced before being exponentially multiplied. This can allow a mutant mitochondrial DNA to dominate the gamete. |
| Mitochondrial DNA mutations |
each mitochondrion has multiple copies of DNA, but mutations can be propogated amongst daughter cells, and eventually produce homozygous cells. Inheritance is only from the mother. |
| Obligate Heterozygote |
Phenotypically normal, but on the basis of pedigree must contain the mutant allele |
| Compound Heterozygote |
2 different mutant alleles of the same gene are present (no normal allele) |
| What is the transmission pattern for X-linked recessive mutations? |
Generally restricted to males (but not all males), rarely seen among females. |
| Locus Heterogeneity |
Same disease phenotype caused by mutation of different genes |
| Name 3 autosomal dominant diseases |
Familial Hypercholesteremia (incomplete), Achondroplasia (incomplete), Huntington Disease |
| What is incompletely dominant inheritance? |
More severe clinical outcome when homozygote vs. heterozygote in autosomal dominant disease. |
| Differentiate Consanguinity from Inbreeding: |
Inbreeding = isolated population that tends to choose partners from within population. Consanguinity = 2 partners inherit a mutant allele from a single distant common ancestor |
| pleiotropy |
multiple, often seemingly unrelated, clinical disorders related to a single mutation |
| Name 2 X-linked recessive disorders: |
Hemophilia A, Androgen Insensitivity Syndrome |
| Relative Risk Ratio (RRR) |
Prevalence of disease in relatives of an affected person/Prevalence in general population |
| Difference in the likelihood of relatives of diseased individuals to report a genetic condition vs. relatives of normal individuals: |
Ascertainment Bias |
| Greater likelihood to know of other family members experiencing the same condition in diseased vs. control groups (due to knowledge of the disease): |
Recall Bias |
| Qualitative vs. Quantitative trait: |
Quantitative = follows Gaussian distribution in population (e.g. large tonsils), Qualitative = present/absent in disease state (e.g. fibroxanthoma) |
| Situations in which monozygotic twins do not have identical genotypes: |
1. somatic rearrangements in T-cell receptor & IgG, 2. X-chromosome inactivation |
| Volunteer-Based vs. Population-Based Ascertainment |
Volunteer-Based = one twin signs on, then recruits other twin. Population-Based = twins sign up for study and their health is subsequently assessed. |
| Heritability (h^2) |
0 if genes contribute nothing to the phenotypic variance. 1 if genes contribute 100%. = (Variance in DZ - Variance in MZ pairs)/(Variance in DZ pairs) |
| Multigenic trait disorders |
e.g. digenic inheritance in Retinitis Pigmentosa, e.g. Idiopathic Cerebral Vein Thrombosis (2 genetic, 1 environmental factor), 3. Hirschprung Disease, 4. Type 1 Diabetes, 5. Alzheimer's |
| Which inheritance pattern shows linear, diagonal, or horizontal inheritance? |
Linear = autosomal dominant, Diagonal = X-linked recessive, Horizontal = autosomal recessive |
| Sarcoma |
Tumor arises in mesenchyme (bone/muscle/connective/nervous system) |
| Carcinoma |
Tumor originates in epithelial tissue (intestine/bronchi/mammary) |
| Gatekeeper Tumor Suppressor Genes |
Control cell growth (regulate checkpoint transitions = gates) |
| Caretaker Tumor Suppressor Genes |
Protect the integrity of the genome (prevent propogation of mutations) |
| What is the mechanism of oncogenesis for ABL? |
Cytoplasmic Tyrosine Kinase, causing Chronic Myelogenous Leukemia. BCR-ABL protein has constitutive tyrosine kinase activity. (bone marrow leukocyte stem cells) |
| What is the mechanism of oncogenesis for CMYC? |
Transcription factor causing Burkitt Lymphoma. MYC gene translocates from 8q to 14q -> unregulated gene expression (B-cells) |
| What is the mechanism of oncogenesis for BCL2? |
Antiapoptotic mitochondrial protein causing Chronic Lymphocytic Leukemia (Bcells). BCL2 translocated from 18q to 14q -> unregulated expression via heavy chain promoter. |
| What is the mechanism of oncogenesis for telomerase? |
Not a primary oncogenic factor, but likely plays a role in maintenance of the cancerous cell proliferation |
| 2-hit hypothesis for cancer |
genotypic heterozygous for one mutation undergoes second somatic mutation to knock out function of the other allele, OR epigenetic changes shut down other allele |
| Loss of heterozygosity (LOH) |
When tumor cells contain two identical mutant alleles at an oncogene locus instead of heterozygous alleles. |
| Mechanisms for LOH |
1. Interstitial deletion (allele loss), 2. Mitotic recombination (allele loss), 3. Mitotic nondisjunction (chromosome loss), 4. Mitotic nondisjunction + duplication (chromosome loss + new copy of chromosome w/mutant gene) |
| What is the difference between genome, chromosome, and gene mutations? |
Genome Mutations = change in # chromosomes, Chromosome Mutations = change structure of single chromsome, Gene Mutation = change in individual gene |
| What are the consequences of missense mutations? |
one codon is replaced with another -> altered protein funtion or altered rate of transcription |
| What are the consequences of Chain Termination Mutations? |
nonsense mutations (inserted/deleted stop codon) -> unstable mRNA leading to decay or unstable protein leading to degradation. |
| What are the consequences of RNA Processing Mutations? |
Alternative RNA splicing sites generated |
| Mutation Hotspot |
Single NT mutations can be transitions (pyrimidine for pyrimidine & purine for purine), or transversions. Hotspots = spontaneous deamination of methylated CpG -> thymidine. Very common mutation. |
| mechanism for large deletions/insertions |
LINE RNA is reverse transcribed into DNA, and can insert randomly into the genome |
| c.365g>a |
cDNA mutation in which a guanine was mutated into an adenine at position 365 |
| g.IVS365+2T>A |
genomic DNA mutation in which the invariant T of the GT 5' splice donor site has been mutated to an A, adjacent to an intervening sequence (used when gene sequence not fully known) |
| g.IVS365-1G>C |
genomic DNA mutation in which the highly conserved G of the 3' AG splice acceptor site is mutated to C. |
| m.365_369delACAC |
deletion of 4 nucleotides of mitochondrial DNA beginning at position 365 |
| m.365_369insACAC |
insertion of 4 nucleotides of mitochondrial DNA beginning at position 365 |
| Glu365X |
nonsense mutation substituting a stop codon for Glutamate 365 |
| dynamic mutation |
variable repeat mutations that accumulate over multiple generations of cells/people |
| Calculating Mutation Rate |
Take # affected individuals from a large n of an autosomal dominant mutation. Mutation rate = # affected/(2 alleles x n) |
| Mutation Rate |
# new mutations/locus/generation (typically in the range of 10^-4 to 10^-6)
|
| Genetic Polymorphism |
mutation found in >1% of a population |
| short tandem repeat polymorphisms (STRP's) |
microsatellites = repeats of 2-5 NT's, multiple repeat lengths (alleles) in the population, readily genotyped. 5-25 copies. |
| variable number tandem repeats (VNTR's) |
minisatellites = repeats of 10-100 NT's. Thousands of copies. |
| Copy Number Polymorphism |
Repeated segments of DNA, tested by array comparative genome hybridization |
| Rh |
+ have antigen RhD, - lack antigen. (-) mothers w/(+) fetuses make Ab's that attack fetal blood = hemolytic disease. Greater risk for subsequent pregnancies. Treatment = Rh antibodies (RhoGam) to mother to reduce exposure to fetal antigens. |
| HLA genes |
human leukocyte antigen genes, class I (A, B, C) and II (DP, DQ, DR) encode proteins that present antigens to the lymphocytes. chromosome 6p, part of MHC, order = class II, then III, then I. |
| HLA inheritance |
clustered on single choromosomal segment 6p (HLA Haplotype), so inherited in entirety from a single chromosome from each parent. Linkage Disequilibrium. |
| Ankylosing Spondilitis |
autoimmune disease of the spine, caused by HLA B27 polymorphism |
| Linkage Disequilibrium |
Occurence of specific combinations of alleles @ linked loci more frequently than predicted. Due to low recombination & closely located genes of a common function. |
| SNP |
2 alleles only corresponding to 2 different bases @ particular site. Occur 1/1000 base pairs. |
| Assumptions in calculating mutation rate: |
1. ascertained cases due to new mutation, 2. full penetration, 3. all new mutations are carried to term, 4. Only 1 mutation can cause the disease |
| Stratification |
Different subpopulations do not interbreed. Increases frequency of autosomal recessive & dominant disease, only minor effect on X-linked disease. |
| Assortative Mating |
positive = people choose mates with similar characteristics to themselves (including disease). Increases frequency of autosomal recessive disease. |
| Consanguinity and Inbreeding |
Consanguinity increases frequency of autosomal recessive disease. |
| Linkage Analysis |
Compares inheritance of particular stretches of DNA with disease incidence within a family tree |
| Association Analysis |
Compare frequency of a particular allele between diseased individuals and controls from the same population |
| =genes located on the same chromosome |
syntenic |
| recombination frequency (theta) |
between 0 (no recombination)and 1/2 (independent assortment) (proportion, not percentage) |
| phase |
knowing which alleles are syntenic in the case of an AaBb individual. On same chromosome homologue = in coupling (cis), on different homologues = in repulsion (trans) |
| LOD score (logarithm of the odds) |
(Z) statistical measure of accuracy per n for recombination events. = [log(10) (likelihood if linked/likelihood if unlinked)]. higher Z = better estimate of theta max. LOD > +3 = odds better than 1000:1 for linkage. |
| linkage equilibrium |
Equilibrium = frequency of allele within a haplotype is the same as the frequency of the allele within the whole population. |
| linkage disequilibrium |
Disequilibrium = genes surrounding disease allele inherited at higher than expected rates. |
| D' |
measure of linkage disequilibrium. 0 = equilibrium, up to 1 = intense disequilibrium. |
| Ancestry Informative Markers |
SNP's that distinguish different ethnicities |
| LD blocks |
clusters of SNPs in high linkage disequilibrium |
| Disease Odds Ratio |
odds of an allele carrier developing a disease = (# diseased allele carriers/# nondiseased carriers)/(# diseased noncarriers/# undiseased noncarriers) |
| Relative Risk Ratio |
measures strength of an odds ratio: (# diseased carriers/all allele carriers)/(# diseased noncarriers/all noncarriers) |
| Limitations of Association Studies |
1. in population stratification, it may be that a particular alleles is associated with a higher risk of disease because multiple alleles are associated with the stratified group (consanguinity), 2. linkage disequilibrium |
| tag SNP's |
minimum set of SNP alleles necessary for defining a haplotype in a LD block |
| What's the best method for mapping short genetic distances? |
linkage disequilibrium (D') |
| How do you calculate the number of possible haplotypes with complete linkage equilibrium? |
2^n (where n = # SNP's) |
| Contiguous Gene Syndrome |
poly-phenotypic disorder caused by deletion of contiguous genes along a chromosome. |
| balanced translocation meiotic assortment |
adjacent 1 (1 of each type of of centromere), adjacent 2 (2 of one type of centromere), alternate = normal/balanced |
| pseudohermaphrodite vs. hermaphrodite |
pseudohermaphrodite = internal sex organs match karyotype. true hermaphrodite = both testes and ovaries are present. |
| Indications for Prenatal Diagnosis by Invasive Testing |
1. Older women, 2. previous child w/ aneuploidy, 3. structural chromosomal abnormality in parent, 4. family history of single-gene disorder, 5. relatives w/neural tube defect, 6. family history of X-linked disorder, 7. + maternal serum/ultrasound screen |
| Amniocentesis |
1. invasive, 2. 2nd trimester 15-16 weeks, 3. amniotic fluid contains fetal cells & urine, 4. test AFP, metabolites, chromosomes, enzyme activity, DNA sequencing |
| alpha fetoprotein as indicator |
immunoassay in maternal serum (MSAFP) or amniotic fluid (AFAFP). high [AFP] indicates anencephaly, spina bifida. (also blood in AF, death, twins, overestimated age |
| chorionic villus sampling |
1. invasive biopsy (tertiary villi), 2. 1st trimester (early advantage) 10-12 weeks, 3. cells derived from fetus, 4. test chromosomes, enzyme activity, DNA sequencing (NOTE: too early for AFP, some mosaicism ambiguity) |
| MSAFP |
catches Down Syndrome (1st trimester) & neural tube defects (2nd trimester) |
| 1st trimester MSAFP screening |
11-13 weeks, measures PAPP-A (low in Down Syndrome) & hCG (high in Down syndrome but low in trisomy 13 & 18) |
| ultrasonography |
2nd trimester & later, look for edema of fetal neck (trisomy marker), other physical abnormalities, growth rate |
| 2nd trimester MSAFP screening |
AFP, hCG, estriol (triple screen). sometimes also inhibin A. All low in all trisomies (except hCG high in Down S) |
| types of mosaicism |
true = detected in multiple colonies from multiple primary cultures, pseudo = seen only in single cell or derived from single primary culture (usually false positive) |
| if unexpected adverse findings from prenatal chromsomes analysis |
karyotype the parents (especially for balanced vs. unbalanced structural rearrangements, and for uniparental disomy in region containing imprinted genes) |
| Prenatal disease treatment & prevention |
termination of pregnancy, metabolic disorder treatment, glucocorticoids for CAH, relief of bladder obstruction, bone marrow transplantation |
| preimplantation genetic diagnosis |
in vitro fertilization, single blasttomere tested (8-16 cells), DNA analysis for single disorder, only conducted if parents/other child has a disorder |
| Genetic screening |
public health initiative to identify individuals at increased risk for genetic disease. screen all members of a large population, regardless of family history. |
| clinical validity vs. utility |
validity = predictive of disease, utility = will cause change to treatment |
| sensitivity vs. specificity |
sensitivity = fraction individuals w/disease who have the tested-for genotype, specificity = fraction of individuals w/out disease who do not have the tested-for genotype |
| positive predictive value |
= % chance of developing the disease given a particular genotype, OR % of people with a genotype that actually have the disease |
| heterozygote screening |
when a high frequency of carriers (e.g. Ashkenazi jews & Tay-Sachs), inexpensive tests, genetic counseling & prenatal diagnosis available, |
| gene flow |
slow diffusion of genes across large populations |
| genetic drift |
in small populations, random effects cause a change in allele frequeny |
| nondirective counseling |
patients provided with information, but are not told what to do regarding testing & managment options |
| conditional probabilities |
depend on whether the individual in question is a carrier |
| What are the odds of 13 successive male births? What are the odds of 13 successive births of a single-sex? |
1. (1/2)^13, 2. 2*(1/2)^13 |
| How are genetic vs. allelic diseases treated? |
genetic = treat symptoms, identify risk for family. allelic = replace defective protein/minimize consequences, genetic counseling, carrier testing, prenatal diagnosis. increasing protein expression only works when mutant protein is partially functional. |
| Diversion Therapy |
use of alternative metabolic pathways to reduce concentration of a harmful metabolite. |
| Treatment of Enzymopathies |
Improve enzyme folding (2-3% improvement, but enough to restore homeostasis). Doesn't work when protein 100% dysfunctional. |
| small molecules therapy for skipping over mutant stop codons |
nonsense mutation = 11% of defects in human genome. experimental therapy, as yet not fully tested. |
| ERT (enzyme replacement therapy) |
1. proteins can be chemically modified (e.g. PEG) to improve pharmacotherapy, 2. intracellular enzymes can be administered extracellularly if substrate is in equilibrium w/extracellular fluid, 3. don't cross BBB, expensive |
| best candidates for ERT |
CNS not involved, only alternative therapies are high risk, human enzyme available in abundance, biology very well understood |
| How are enzymes for Gaucher's Disease targeted to particular cell types & organelles? |
modification of the carbohydrates normally decorating the glycoprotein enzyme: terminal sugars are removed & core alpha mannosyl residues target macrophages (then delivered to lysosomes intracellularly) |
| What gene expression targeted treatments are appropriate for sickle cell anemia? |
DNA hypomethylation increases expression of fetal Hb |
| Nuclear Transplantation |
= nuclear cloning, transfer of diploid nucleus from adult donor somatic cell into an oocyte cytoplasm |
| Therapeutic cloning |
uses embryonic stem cells generated by nuclear trnsplantation to form mature differentiated cell types in culture, for transplantation into the donor w/no immune rejection |
| reproductive cloning |
reimplanting an embryo obtained by nuclear trnsplantation into the uterus of a surrogate mother -> clone of donor human |
| What are some examples of genetic disorders treated by hematopoietic stem cell transplantation? |
cancer, severe combined immunodeficiency (e.g. beta-thalassemia). Transplanted stem cells release enzymes that are taken up by native cells containing the k/o mutation. Brain perivascular microglia come from marrow. homozygous normal best. |
| source of hematopoietic stem cells |
bone marrow, placental cord blood (more tolerable for histoincompatibility, widely available, risk of graft-vs.-host disease is reduced) |
| what are the essential requirements of gene therapy for an inherited disorder? |
1. known gene identity, 2. cDNA clone, 3. known disease pathophysiology, 4. good risk-to-benefit ratio, 5. low consequences of over/underexpression, 6. target cell w/ long half-life or replicative, 7. successful animal studies, 8. governmental oversight |
| ex vivo vs. in vivo gene therapy |
ex vivo = gene injected into cells in vitro that are then introduced into the body. in vivo = gene introduced directly into the patient via viruses |
| episome |
circular viral DNA containing a normal copy of a gene to replace a mutant allele. good for long-lived cells |
| Uses for gene therapy |
1. replace mutant gene, 2. inactivate dominant allele, 3. administer pharmacotherapy in vivo |
| ex vivo vs. in vivo gene therapy |
|
| retrovirus DNA transfer |
= RNA viruses, incapable of replication, non-cytotoxic, up to 8kb DNA, low copy number inserted. Usually target cell must undergo mitosis, but Lentiviruses (eg. HIV) work in non-dividing cells. |
| adeno-associated viruses in DNA transfer |
no adverse effects in humans, infect all cells. Inserts only up to 5 b. |
| adenoviruses in DNA transfer |
easy to produce (high titer), infect all cells, inserts of 30 to 35 kb. Associated w/death due to immune reaction. |
| nonviral vectors for DNA transfer |
naked DNA, DNA in liposomes, protein-DNA conjugates (where protein binds receptor for transport, etc.), artificial chromosomes. |
| limited success of nonviral vectors |
DNA tends to be degraded by lysosomes, remaining DNA mostly does not enter the nucleus, inefficient delivery |